{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:24:34Z","timestamp":1792718674233,"version":"4.5.0"},"reference-count":146,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1339,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1111\/j.1529-8019.2012.01520.x","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T14:37:26Z","timestamp":1337179046000},"page":"55-69","source":"Crossref","is-referenced-by-count":31,"title":["Antibiotic overuse and resistance in dermatology"],"prefix":"10.1155","volume":"25","author":[{"given":"SUSAN Y.","family":"CHON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUNG Q.","family":"DOAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RANA MAJD","family":"MAYS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SELINA M.","family":"SINGH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RACHEL A.","family":"GORDON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEPHEN K.","family":"TYRING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2012,5,16]]},"reference":[{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5694\/j.1326-5377.1998.tb140250.x","article-title":"Systematic review of Propionibacterium acnes resistance to systemic antibiotics","volume":"169","author":"Cooper","year":"1998","journal-title":"Med J Aust"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2133.2003.05067.x","article-title":"Antibiotic-resistant acne: lessons from Europe","volume":"148","author":"Ross","year":"2003","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1111\/j.1529-8019.2012.01520.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archdermatol.2011.67","article-title":"Antibiotics, acne, and Staphylococcus aureus colonization","volume":"147","author":"Fanelli","year":"2011","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.139.4.467","article-title":"Effect of antibiotics on the oropharyngeal flora in patients with acne","volume":"139","author":"Levy","year":"2003","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1346-8138.1994.tb01728.x","article-title":"Sensitivity of Staphylococcus aureus and Streptococcus pyogenes isolated from skin infections in 1992 to antimicrobial agents","volume":"21","author":"Nishijima","year":"1994","journal-title":"J Dermatol"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01520.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1610-0387.2006.06053.x","article-title":"Systemic antibiotic therapy of acne vulgaris","volume":"4","author":"Ochsendorf","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1542\/peds.2005-2022","article-title":"Expert committee recommendations for acne management","volume":"118","author":"Zaenglein","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB8|cit8","first-page":"22","article-title":"In-vivo effectiveness of adapalene 0.1%\/benzoyl peroxide 2.5% gel on antibiotic-sensitive and resistant Propionibacterium acnes","volume":"4","author":"Leyden","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB9|cit9","first-page":"26","article-title":"A community-based study of the effectiveness of doxycycline 40\u2003mg (30-mg immediate-release and 10-mg delayed-release beads) on quality of life and satisfaction with treatment in participants with rosacea","volume":"86","author":"Baldwin","year":"2011","journal-title":"Cutis"},{"issue":"11","key":"10.1111\/j.1529-8019.2012.01520.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1610-0387.2011.07723.x","article-title":"Treatment of ocular rosacea with 40\u2003mg doxycycline in a slow release form","volume":"9","author":"Pfeffer","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB11|cit11","first-page":"549","article-title":"Erythromycin-resistance of cutaneous bacterial flora in acne","volume":"11","author":"Dreno","year":"2001","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000067822","article-title":"Propionibacterium acnes resistance: a worldwide problem","volume":"206","author":"Eady","year":"2003","journal-title":"Dermatology"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.1992.tb00104.x","article-title":"Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy","volume":"126","author":"Harkaway","year":"1992","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.1994.tb08519.x","article-title":"Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients","volume":"131","author":"Eady","year":"1994","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2133.1996.tb07847.x","article-title":"The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria","volume":"134","author":"Eady","year":"1996","journal-title":"Br J Dermatol"},{"issue":"14","key":"10.1111\/j.1529-8019.2012.01520.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa043252","article-title":"Methicillin-resistant Staphylococcus aureus disease in three communities","volume":"352","author":"Fridkin","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/499815","article-title":"Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections","volume":"42","author":"Seybold","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1111\/j.1529-8019.2012.01520.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1097\/00006454-199312003-00004","article-title":"Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children","volume":"12","author":"Hebert","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"C","key":"10.1111\/j.1529-8019.2012.01520.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/37.suppl_C.125","article-title":"A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and\/or soft tissue infections","volume":"37","author":"Montero","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.2007.08308.x","article-title":"A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris","volume":"158","author":"Langner","year":"2008","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1468-3083.2006.01884.x","article-title":"A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris","volume":"21","author":"Langner","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00128071-200102040-00007","article-title":"The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study","volume":"2","author":"Leyden","year":"2001","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/120347540100500109","article-title":"The efficacy and safety of a combination benzoyl peroxide\/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide\/erythromycin combination product","volume":"5","author":"Leyden","year":"2001","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijantimicag.2011.03.007","article-title":"Two paediatric cases of skin and soft-tissue infections due to clindamycin-resistant Staphylococcus aureus carrying a plasmid-encoded vga(A) allelic variant for a putative efflux pump","volume":"38","author":"Qin","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1471-2334-10-351","article-title":"Fusidic acid and clindamycin resistance in community-associated, methicillin-resistant Staphylococcus aureus infections in children of Central Greece","volume":"10","author":"Katopodis","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/JCM.02208-10","article-title":"Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii","volume":"49","author":"Chen","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/JCM.42.4.1800-1802.2004","article-title":"Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing","volume":"42","author":"Jorgensen","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01520.x-BIB28|cit28","first-page":"724","article-title":"Antibiotic resistance: an editorial review with recommendations","volume":"10","author":"Rosen","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB29|cit29","first-page":"923","article-title":"MRSA colonisation (eradicating colonisation in people without active\/invasive infection)","volume":"1","author":"Bradley","year":"2011","journal-title":"Clin Evid (Online)"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1086\/647125","article-title":"Mupirocin resistance: clinical and molecular epidemiology","volume":"16","author":"Bradley","year":"1995","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1592\/phco.29.3.263","article-title":"Agents for the decolonization of methicillin-resistant Staphylococcus aureus","volume":"29","author":"McConeghy","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.10.3.505","article-title":"Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks","volume":"10","author":"Kluytmans","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1111\/j.1529-8019.2012.01520.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1086\/501956","article-title":"Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains","volume":"22","author":"Semret","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000112312","article-title":"Intranasal mupirocin prophylaxis in elective surgery. A review of published studies","volume":"54","author":"Trautmann","year":"2008","journal-title":"Chemotherapy"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0196-6553(95)90061-6","article-title":"Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents","volume":"23","author":"Watanakunakorn","year":"1995","journal-title":"Am J Infect Control"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01520.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1086\/377735","article-title":"Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review","volume":"37","author":"Laupland","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01520.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1111\/j.1529-8019.2012.01520.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1056\/NEJMvcm071319","article-title":"Videos in clinical medicine. Abscess incision and drainage","volume":"357","author":"Fitch","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1111\/j.1529-8019.2012.01520.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1128\/AAC.00377-07","article-title":"Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection","volume":"51","author":"Rajendran","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB41|cit41","unstructured":"Gorwitz RJ Jernigan DB Powers JH Jernigan JA Participants in the CDC Convened Experts' Meeting on Management of MRSA in the Community Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention 2006 http:\/\/www.cdc.gov\/ncidod\/dhqp\/ar_mrsa_ca.html"},{"issue":"9725","key":"10.1111\/j.1529-8019.2012.01520.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0140-6736(09)61999-1","article-title":"Community-associated meticillin-resistant Staphylococcus aureus","volume":"375","author":"Deleo","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01520.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1111\/j.1529-8019.2012.01520.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","article-title":"Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection","volume":"290","author":"Naimi","year":"2003","journal-title":"JAMA"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01520.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/AAC.00206-07","article-title":"Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus","volume":"51","author":"Cenizal","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/AAC.01244-06","article-title":"Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic","volume":"51","author":"Szumowski","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/128.Supplement_3.S437","article-title":"Mechanism of action of trimethoprim-sulfamethoxazole. II","volume":"128","author":"Burchall","year":"1973","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB48|cit48","volume-title":"Drug facts and comparisons","volume":"60","author":"Wickersham","year":"2006"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB49|cit49","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"MacDougall","year":"2011"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/JCM.44.1.108-118.2006","article-title":"Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States","volume":"44","author":"Tenover","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1111\/j.1529-8019.2012.01520.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/AAC.34.8.1611","article-title":"Gene heterogeneity for tetracycline resistance in Staphylococcus spp","volume":"34","author":"Bismuth","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01520.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/598510","article-title":"Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300","volume":"48","author":"Schwartz","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijantimicag.2006.04.013","article-title":"Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea","volume":"28","author":"Raveh","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/INF.0b013e3181826e5e","article-title":"Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections","volume":"28","author":"Hyun","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01520.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/archpedi.159.10.980","article-title":"Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital","volume":"159","author":"Purcell","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.inf.0000164162.00163.9d","article-title":"Treatment of community-associated methicillin-resistant Staphylococcus aureus infections","volume":"24","author":"Kaplan","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.AOG.0000175142.79347.12","article-title":"Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy","volume":"106","author":"Laibl","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1086\/511041","article-title":"A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection","volume":"44","author":"Miller","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jac\/15.5.523","article-title":"In-vitro activity of mupirocin (\u201cpseudomonic acid\u201d) against clinical isolates of Staphylococcus aureus","volume":"15","author":"Casewell","year":"1985","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/AAC.33.2.156","article-title":"Mechanism of mupirocin transport into sensitive and resistant bacteria","volume":"33","author":"Capobianco","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"issue":"8555","key":"10.1111\/j.1529-8019.2012.01520.x-BIB61|cit61","first-page":"387","article-title":"Mupirocin-resistant Staphylococcus aureus","volume":"2","author":"Baird","year":"1987","journal-title":"Lancet"},{"issue":"12","key":"10.1111\/j.1529-8019.2012.01520.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1128\/AAC.32.12.1780","article-title":"Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo","volume":"32","author":"Goldfarb","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1111\/j.1529-8019.2012.01520.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/647242","article-title":"Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment","volume":"17","author":"Miller","year":"1996","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0002-9343(93)90147-H","article-title":"Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment","volume":"94","author":"Kauffman","year":"1993","journal-title":"Am J Med"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10096-001-0677-x","article-title":"Strain variation in the MRSA population over a 10-year period in one Dublin hospital","volume":"21","author":"Rossney","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0732-8893(02)00388-7","article-title":"Mupirocin resistance in methicillin-resistant Staphylococcus aureus clinical isolates in a Spanish hospital. Co-application of multiplex PCR assay and conventional microbiology methods","volume":"43","author":"Perez-Roth","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/ajkd.2002.30553","article-title":"Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis","volume":"39","author":"Perez-Fontan","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/520663","article-title":"Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit","volume":"45","author":"Jones","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1529-8019.2008.00190.x","article-title":"Local antibiotics in dermatology","volume":"21","author":"Gelmetti","year":"2008","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2007.07.050","article-title":"Allergic contact dermatitis to topical antibiotics: epidemiology, responsible allergens, and management","volume":"58","author":"Gehrig","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/clinids\/17.3.466","article-title":"Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group","volume":"17","author":"Doebbeling","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1086\/501633","article-title":"Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization","volume":"20","author":"Soto","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01520.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archinte.1996.00040041109010","article-title":"A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection","volume":"156","author":"Raz","year":"1996","journal-title":"Arch Intern Med"},{"issue":"A","key":"10.1111\/j.1529-8019.2012.01520.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0195-6701(01)90005-2","article-title":"MRSA patients: proven methods to treat colonization and infection","volume":"48","author":"Boyce","year":"2001","journal-title":"J Hosp Infect"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1128\/AAC.01608-10","article-title":"Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections","volume":"56","author":"Miller","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"d5694","DOI":"10.1136\/bmj.d5694","article-title":"Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation","volume":"343","author":"Robotham","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jhin.2010.11.002","article-title":"Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital","volume":"77","author":"Lee","year":"2011","journal-title":"J Hosp Infect"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaad.2003.06.005","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem","volume":"50","author":"Cohen","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01520.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1086\/429827","article-title":"Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men","volume":"40","author":"Lee","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1017\/S1481803500011635","article-title":"Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors","volume":"11","author":"Adam","year":"2009","journal-title":"CJEM"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkg466","article-title":"Managing skin and soft tissue infections: expert panel recommendations on key decision points","volume":"52","author":"Eron","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"e959","DOI":"10.1542\/peds.2008-2428","article-title":"Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus","volume":"123","author":"Elliott","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB83|cit83","first-page":"CD003261","article-title":"Interventions for impetigo","author":"Koning","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"7457","key":"10.1111\/j.1529-8019.2012.01520.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/bmj.329.7457.95","article-title":"Common skin infections in children","volume":"329","author":"Sladden","year":"2004","journal-title":"BMJ"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1365-2133.2008.08485.x","article-title":"Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial","volume":"158","author":"Koning","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000107776","article-title":"Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study","volume":"215","author":"Oranje","year":"2007","journal-title":"Dermatology"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2006.08.058","article-title":"Topical retapamulin ointment (1%, wt\/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial","volume":"55","author":"Parish","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"E","key":"10.1111\/j.1529-8019.2012.01520.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/31.suppl_E.103","article-title":"A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections","volume":"31","author":"Rodriguez-Solares","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0011-393X(98)85036-4","article-title":"Comparision of two regimens of oral clindamycin versus dicloxacillin in the treatment of mild to moderate skin and soft tissue infections","volume":"59","author":"Blaszcyk-Kostanecka","year":"1998","journal-title":"Curr Ther Res Clin Exp"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jaad.2003.12.043","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak","volume":"50","author":"Iyer","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3201\/eid1106.040641","article-title":"Staphylococcus aureus in community-acquired skin infections","volume":"11","author":"Moran","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0149-2918(01)80043-6","article-title":"Linezolid: an oxazolidinone antimicrobial agent","volume":"23","author":"Fung","year":"2001","journal-title":"Clin Ther"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/9781420017236.005","volume-title":"Antimicrobial resistance: problem pathogens and clinical countermeasures","volume":"48","author":"Moise","year":"2007"},{"issue":"11","key":"10.1111\/j.1529-8019.2012.01520.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1128\/AAC.49.11.4658-4666.2005","article-title":"Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam","volume":"49","author":"Breedt","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2165\/00003495-199448020-00004","article-title":"Optimum outpatient therapy of skin and skin structure infections","volume":"48","author":"Failla","year":"1994","journal-title":"Drugs"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2007.04.004","article-title":"Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa","volume":"57","author":"Yu","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/ijerph8020554","article-title":"Prevalence and antimicrobial-resistance of Pseudomonas aeruginosa in swimming pools and hot tubs","volume":"8","author":"Lutz","year":"2011","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jaad.2003.12.034","article-title":"Skin diseases associated with Malassezia species","volume":"51","author":"Gupta","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-4632.2009.04377.x","article-title":"Topical photodynamic therapy with methyl aminolevulinate may be an alternative therapeutic option for the recalcitrant Malassezia folliculitis","volume":"50","author":"Lee","year":"2011","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1468-3083.2004.00938.x","article-title":"Intramuscular bipenicillin vs. intravenous penicillin in the treatment of erysipelas in adults: randomized controlled study","volume":"18","author":"Zeglaoui","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/AAC.24.5.679","article-title":"Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children","volume":"24","author":"Fleisher","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01645222","article-title":"The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas","volume":"12","author":"Jorup-Ronstrom","year":"1984","journal-title":"Infection"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01520.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"553","DOI":"10.5694\/j.1326-5377.1996.tb138641.x","article-title":"Case survey of management of cellulitis in a tertiary teaching hospital","volume":"165","author":"Aly","year":"1996","journal-title":"Med J Aust"},{"issue":"9","key":"10.1111\/j.1529-8019.2012.01520.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-4632.2010.04464.x","article-title":"Analysis of epidemiology, clinical features and management of erysipelas","volume":"49","author":"Krasagakis","year":"2010","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/QCO.0b013e32805dfb2d","article-title":"Acute bacterial skin infections and cellulitis","volume":"20","author":"Gabillot-Carre","year":"2007","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"10.1111\/j.1529-8019.2012.01520.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/2047-783X-15-12-554","article-title":"Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin","volume":"15","author":"Eckmann","year":"2010","journal-title":"Eur J Med Res"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01520.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/JCM.00202-09","article-title":"emm1\/sequence type 28 strains of group A streptococci that express covR at early stationary phase are associated with increased growth and earlier SpeB secretion","volume":"47","author":"Chiang-Ni","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB108|cit108","doi-asserted-by":"crossref","DOI":"10.1111\/j.1469-0691.2011.03624.x","article-title":"Invasive group A streptococcal infections in adults, France (2006-2010)","author":"Plainvert","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-540-78814-0_14","volume-title":"Therapy of skin diseases: a worldwide perspective on therapeutic approaches and their molecular basis","author":"French","year":"2010"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1967.01600340019005","article-title":"The scalded skin syndrome in small children","volume":"95","author":"Lowney","year":"1967","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00128071-200304030-00003","article-title":"Staphylococcal scalded skin syndrome: diagnosis and management","volume":"4","author":"Patel","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00221387","article-title":"The epidermolytic (exfoliative) toxins of Staphylococcus aureus","volume":"184","author":"Bailey","year":"1995","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB113|cit113","first-page":"109","volume-title":"Emergency dermatology","author":"Ruocco","year":"2010"},{"issue":"11","key":"10.1111\/j.1529-8019.2012.01520.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/81385","article-title":"Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1","volume":"6","author":"Amagai","year":"2000","journal-title":"Nat Med"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01520.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1523-1747.2002.01751.x","article-title":"Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1","volume":"118","author":"Amagai","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1111\/j.1529-8019.2012.01520.x-BIB116|cit116","first-page":"722","article-title":"Staphylococcal scalded skin syndrome caused by exfoliative toxin B-producing methicillin-resistant Staphylococcus aureus","volume":"155","author":"Yokota","year":"1996","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2133.1999.02721.x","article-title":"Staphylococcal scalded skin syndrome in an adult associated with methicillin-resistant Staphylococcus aureus","volume":"140","author":"Acland","year":"1999","journal-title":"Br J Dermatol"},{"issue":"26","key":"10.1111\/j.1529-8019.2012.01520.x-BIB118|cit118","first-page":"873","article-title":"Cephalosporin susceptibility among Neisseria gonorrhoeae isolates - United States, 2000-2010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0163-4453(88)96249-4","article-title":"Outbreak of staphylococcal scalded skin syndrome among neonates","volume":"16","author":"Dancer","year":"1988","journal-title":"J Infect"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1086\/498901","article-title":"A clinical and microbiological comparison of Staphylococcus aureus toxic shock and scalded skin syndromes in children","volume":"42","author":"Chi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB121|cit121","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent mycobacterium tuberculosis infection","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-17","key":"10.1111\/j.1529-8019.2012.01520.x-BIB122|cit122","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1469-0691.2011.03556.x","article-title":"Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis","volume":"17","author":"Borrell","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1469-0691.2011.03577.x","article-title":"Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis","volume":"17","author":"Sougakoff","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1993.03510010071032","article-title":"Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance","volume":"270","author":"Mahmoudi","year":"1993","journal-title":"JAMA"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0923-2508(93)90023-U","article-title":"Multidrug-resistant tuberculosis and its control","volume":"144","author":"Kochi","year":"1993","journal-title":"Res Microbiol"},{"key":"10.1111\/j.1529-8019.2012.01520.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-0-387-72418-8_5","volume-title":"Antimicrobial resistance and implications for the 21st century","author":"Davies","year":"2008"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB128|cit128","first-page":"138","article-title":"A controlled trial of a 2-month, 3-month, and 12-month regimens of chemotherapy for sputum smear-negative pulmonary tuberculosis: the results at 30 months. Hong Kong Chest Service\/Tuberculosis Research Centre, Madras\/British Medical Research Council","volume":"124","year":"1981","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01520.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1164\/ajrccm\/136.6.1339","article-title":"Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service\/British Medical Research Council","volume":"136","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"4 Pt 1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB130|cit130","first-page":"700","article-title":"Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service\/British Medical Research Council","volume":"143","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01520.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1164\/rccm.200901-0078OC","article-title":"Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis","volume":"180","author":"Dorman","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/AAC.47.2.653-657.2003","article-title":"Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis","volume":"47","author":"Hu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1111\/j.1529-8019.2012.01520.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1164\/rccm.200305-682OC","article-title":"The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis","volume":"168","author":"Gosling","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"RR-11","key":"10.1111\/j.1529-8019.2012.01520.x-BIB135|cit135","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2006","volume":"55","author":"Workowski","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1111\/j.1529-8019.2012.01520.x-BIB136|cit136","first-page":"101","article-title":"Mass treatment\/prophylaxis during an outbreak of infectious syphilis in Vancouver, British Columbia","volume":"26","author":"Rekart","year":"2000","journal-title":"Can Commun Dis Rep"},{"issue":"8","key":"10.1111\/j.1529-8019.2012.01520.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00007435-200208000-00010","article-title":"A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis","volume":"29","author":"Hook","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1574-6968.1998.tb13312.x","article-title":"Identification and sequence analysis of Treponema pallidum tprJ, a member of a polymorphic multigene family","volume":"169","author":"Stamm","year":"1998","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB139|cit139","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa040216","article-title":"Macrolide resistance in Treponema pallidum in the United States and Ireland","volume":"351","author":"Lukehart","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01520.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1586\/eri.11.103","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management","volume":"9","author":"Ison","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"23","key":"10.1111\/j.1529-8019.2012.01520.x-BIB141|cit141","first-page":"349","article-title":"Antimicrobial resistance in gonococci, WHO Western Pacific Region, 1996. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme","volume":"21","year":"1997","journal-title":"Commun Dis Intell"},{"issue":"11","key":"10.1111\/j.1529-8019.2012.01520.x-BIB142|cit142","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/AAC.49.11.4804-4806.2005","article-title":"Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis","volume":"49","author":"Solomon","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1111\/j.1529-8019.2012.01520.x-BIB143|cit143","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1286-4579(02)01639-8","article-title":"Haemophilus ducreyi: clinical features, epidemiology, and prospects for disease control","volume":"4","author":"Bong","year":"2002","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01520.x-BIB144|cit144","first-page":"54","article-title":"Treating chancroid: summary of studies in southern Africa","volume":"65","author":"Ballard","year":"1989","journal-title":"Genitourin Med"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01520.x-BIB145|cit145","first-page":"185","article-title":"Drug resistance of Haemophilus ducreyi","volume":"21","author":"Rutanarugsa","year":"1990","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01520.x-BIB146|cit146","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/AAC.22.4.686","article-title":"Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg","volume":"22","author":"Bilgeri","year":"1982","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2012.01520.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2012.01520.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:58:42Z","timestamp":1671818322000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2012.01520.x"}},"subtitle":["Antibiotic overuse and resistance in dermatology"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01520.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}